Last reviewed 2026-04-20 · How we verify

Lovenox

At a glance

Approved indications

• Deep venous thrombosis
• Myocardial infarction
• Prevention of clot formation during haemodialysis
• Prevention of venous thromboembolism
• Pulmonary embolism
• Unstable angina

Common side effects

• Bleeding
• Anemia
• Thrombocytopenia
• Elevation of serum aminotransferase
• Diarrhea
• Nausea
• Ecchymosis
• Fever
• Edema
• Peripheral edema
• Dyspnea
• Confusion

Serious adverse events

• Hemorrhage - Abdominal Surgery
• Hemorrhage - Colorectal Surgery
• Hemorrhage - Hip Replacement Surgery (without extended prophylaxis)
• Hemorrhage - Hip Replacement Surgery (peri-operative)
• Injection site hematomas (extended prophylaxis hip replacement)
• Intracranial hemorrhage
• Retroperitoneal hemorrhage
• Intraocular hemorrhage

Key clinical trials

• Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO (PHASE2)
• Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX) (PHASE4)
• Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management (NA)
• A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty (PHASE3)
• Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction (NA)
• REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults (PHASE3)
• A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants (PHASE2)
• Impact Of Laparoscopic Sleeve Gastrectomy On Obesity-Related Comorbidities In Patients Over 65 Years (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.